The dialogue between diabetes and diastole

European Journal of Heart Failure

Volumn 11, Issue 1, 2009, Pages 3-5

  Van Heerebeek, Loek ^a   Paulus, Walter J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CONGESTIVE CARDIOMYOPATHY; CORONARY FLOW RESERVE; DIASTOLIC DYSFUNCTION; EDITORIAL; GLYCEMIC CONTROL; HEALTH SURVEY; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERGLYCEMIA; HYPERTENSION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; WEIGHT GAIN; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIASTOLE; NOTE; PATHOPHYSIOLOGY; PHYSIOLOGY;

DIABETES MELLITUS; DIABETIC ANGIOPATHIES; DIASTOLE; HUMANS; HYPERGLYCEMIA; VENTRICULAR DYSFUNCTION, LEFT;

EID: 62449281043     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfn033     Document Type: Editorial

References (21)

1. Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 1972;30:595-602.
2. Zarich SW, Arbuckle BE, Cohen LR, Roberts M, Nesto RW. Diastolic abnormalities in young asymptomatic diabetic patients assessed by pulsed Doppler echocardiography. J Am Coll Cardiol 1988;12:114-120.
3. Diamant M, Lamb HJ, Groeneveld Y, Endert EL, Smit JW, Bax JJ, Romijn JA, de Roos A, Radder JK. Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus. J Am Coll Cardiol 2003;42:328-335.
4. Berg TJ, Snorgaard O, Faber J, Torjesen PA, Hildebrandt P, Mehlsen J, Hanssen KF. Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes. Diabetes Care 1999;22: 1186.
5. Von Bibra H, Hansen A, Dounis V, Bystedt T, Malmberg K, Ryden L. Augmented metabolic control improves myocardial diastolic function and perfusion in patients with non-insulin dependent diabetes. Heart 2004;90:1483-1484.
6. Jarnert C, Landstedt-Hallin L, Malmberg K, Melcher A, Ohrvik J, Persson H, Ryden L. A randomized trial of the impact of strict glycaemic control on myocardial diastolic function and perfusion reserve: a report from the DADD (Diabetes mellitus And Diastolic Dysfunction) study. EurJ Heart Fail 2009;11:39-47.
7. Van Heerebeek L, Paulus WJ. Invasive evaluation of diastolic left ventricular dysfunction. In Smiseth O, Tendera M. Diastolic Heart Failure (eds), London: Springer; 2007. p137-148.
8. Fischer M, Baessler A, Hense HW, Hengstenberg C, Muscholl M, Holmer S, Doring A, Broeckel U, Riegger G, Schunkert H. Prevalence of left ventricular diastolic dysfunction in the community: results from a Doppler echocardiographic-based survey of a population sample. Eur Heart J 2003;24:320-328.
9. Klapholz M, Maurer M, Lowe AM, Messineo F, Meisner JS, Mitchell J, Kalman J, Phillips RA, Steingart R, Brown EJ Jr, Berkowitz R, Moskowitz R, Soni A, Mancini D, Bijou R, Sehhat K, Varshneya N, Kukin M, Katz SD, Sleeper LA, Le Jemtel TH, and New York Heart Failure Consortium. Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: Results of the New York heart failure registry. J Am Coll Cardiol 2004;43: 1432-1438.
10. Opie LH. Metabolic syndrome. Circulation 2007;115:e32-e35.
11. Ilercil A, Devereux RB, Roman MJ, Paranicas M, O'Grady MJ, Lee ET, Welty TK, Fabsitz RR, Howard BV. Associations of insulin levels with left ventricular structure and function in American Indians: the strong heart study. Diabetes 2002; 51:1543-1547.
12. Paulus WJ, Tschöpe C, Sanderson JE, Rusconi C, Flachskampf FA, Rademakers FE, Marino P, Smiseth OA, De Keulenaer G, Leite-MCircira AF, Borbély A, Édes I, Handoko ML, Heymans S, Pezzali N, Pieske B, Dickstein K, Fraser AG, Brutsaert DL. How to diagnose diastolic heart failure? A consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction (HFNEF) by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 2007;28:2539-2550.
13. Emery WT, Jadavji I, Choy JB, Lawrance RA. Investigating the European Society of Cardiology guidelines in a practical scenario. Eur J Echocardiogr 2008;9: 685-691.
14. Handoko ML, Paulus WJ. Polishing the diastolic dysfunction measurement stick. EurJ Echocardiogr 2008;9:575-577.
15. Cosson S, Kevorkian JP, Virally ML, Henry P, Laloi-Michelin M, Meas T, Beaufils P, Guillausseau PJ. No evidence for left ventricular diastolic dysfunction in asymptomatic normotensive type 2 diabetic patients: a case-control study with new echo-cardiographic techniques. Diabetes Metab 2007;33:61-67.
16. BoyerJK, Thanigaraj S, Schechtman KB, Perez JE. Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus. Am J Cardiol 2004;93:870-875.
17. Poornima IG, Parikh P, Shannon RP. Diabetic cardiomyopathy: the search for a unifying hypothesis. Circ Res 2006;98:596-605.
18. Boudina S, Abel ED. Diabetic cardiomyopathy revisited. Circulation 2007;115: 3213-3223.
19. Von Bibra H, Diamant M, Scheffer PG, Siegmund T, Schumm-Draeger PM. Rosi-glitazone, but not glimepiride, improves myocardial diastolic function in association with reduction in oxidative stress in type 2 diabetic patients without overt heart disease. Diabetes Vasc Dis Res 2008;5:310-318.
20. Van Heerebeek L, Hamdani N, Handoko L, Falcao-Pires I, Musters RJ, Kupreishvili K, Ijsselmuiden AJJ, Schalkwijk CG, Bronzwaer JGF, Diamant M, Borbely A, van der Velden J, Stienen GJM, Laarman GJ, Niessen HWM, Paulus WJ. Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation endproducts and myocyte resting tension. Circulation 2008; 117:43-51.
21. Carroll JF, Summers RL, Dzielak DJ, Cockrell K, Montani JP, Mizelle HL Diastolic compliance is reduced in obese rabbits. Hypertension 1999;33:811-815.